U-Systems Receives 2012 Breast Imaging Entrepreneurial Company of the Year Award

SAN JOSE, Calif.--(BUSINESS WIRE)--U-Systems, the leader in automated breast ultrasound (ABUS) technology, received the 2012 North American Entrepreneurial Company of the Year honors in Breast Imaging at a national awards event hosted by Frost & Sullivan and held at the Fairmont Hotel in San Jose. The Frost & Sullivan award recognizes U-Systems’ dedication to addressing the challenges of breast ultrasound screening and the ability to bring innovation in its efforts to make breast ultrasound a viable tool for routine breast cancer screening.

“As a result, U-Systems is on track for significant growth in 2012 and destined to become a key contender in the North American breast imaging equipment market.”

“Through its provision of an automated breast ultrasound (ABUS) solution that reduces breast ultrasound screening exam times while improving the accuracy of breast cancer detection in women with dense breast tissue, U-Systems addresses some of the biggest challenges in breast imaging today. Designed specifically for high-volume clinical environments, U-Systems’ somo•v® ABUS device overcomes the ultrasound modality’s limitations as an adjunct to mammography and has potential to emerge as a life-saving diagnostic aid that enables physicians to effectively diagnose the breast cancers missed by mammography,” said Frost & Sullivan Industry Analyst Roberto G. Aranibar. “As a result, U-Systems is on track for significant growth in 2012 and destined to become a key contender in the North American breast imaging equipment market.”

“Recognizing excellence in the development of the somo•v ABUS system, Frost & Sullivan highlighted that the technology has emerged as an efficient, cost-effective, patient-friendly choice for breast scans,” said Ron Ho, president and CEO of U-Systems. “We are proud to be recognized for our somo•v ABUS technology as this continues to validate the need new approaches to improve early detection in women with dense breast tissue and the significant resources we have dedicated to develop the somo•v ABUS system as well as establishing a solid scientific basis for the use of ABUS as a cancer screening tool for women with dense breast tissue.”

The somo•v ABUS system has received an approvable letter from the U.S. Food and Drug Administration (FDA) for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue. When approved, the somo•v will be the only ultrasound device approved for breast cancer screening in the United States, Canada and 27 European Union countries.

Using proprietary technology to automate the ultrasound imaging process, the U-Systems’ somo•v ABUS system was developed specifically for the high-volume, breast cancer screening environment. The somo•VIEWer™ Advanced 3D Workstation enables fast, accurate review and archive of patient exams, optimizing breast ultrasound screening workflow.

Each year, Frost & Sullivan presents the Entrepreneurial Company of the Year Award to the company that has demonstrated entrepreneur spirit by devising a strong growth strategy and robustly implementing it. The award recognizes the recipient’s strength in terms of innovation in products/technologies, leadership in customer value and speedy response to market needs.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About U-Systems

As the leader in automated breast ultrasound technology U-Systems is establishing the standard for breast ultrasound screening. The U-Systems’ somo•v Automated Breast Ultrasound (ABUS) system and somo•VIEWer Advanced 3D Workstation are cleared under 510(k) for diagnostic use as an adjunct to mammography. For more information about U-Systems, please visit our website at http://www.u-systems.com.